Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Entod Pharmaceuticals Appoints Balasubramanian K Pillai As Chief Financial Officer

PRIVATEMar 18, 2025•about 1 year ago

Position

Chief Financial Officer

Company

Entod Pharmaceuticals

Balasubramanian K Pillai
MumbaiManufacturingBiotechnologyPharmaceutical

Description

Entod Pharmaceuticals has announced the appointment of Balasubramanian K Pillai as its new Chief Financial Officer (CFO). With over 26 years of experience in leadership roles across various industries and global markets, Pillai brings expertise in financial planning, risk management, and business growth.

Company Information

Company

Entod Pharmaceuticals

Location

Mumbai, Maharashtra, India

About

ENTOD Pharmaceuticals is an international research-based pharmaceutical organisation with over three decades of pharmaceutical expertise in Ophthalmology, ENT and Dermatological medicine. Globally we have over 250 products in our portfolio, state-of-the-art manufacturing & research facilities, a global workforce of over 2000 and highly experienced Quality Assurance, Production and R&D teams. Our products are sold in over 67 countries including the EU, UK , Africa and Asia. Our quality systems are certified in Europe and our manufacturing quality standards adheres to international GMP norms.

Predictive Intelligence
Strategic

ML-powered predictions for Entod Pharmaceuticals's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.